Tenaya therapeutics receives $8 million clinical grant from california institute for regenerative medicine

Funding will support ongoing ridge™ -1 clinical trial of tn-401 gene therapy for the potential treatment of pkp2-associated arrhythmogenic right ventricular cardiomyopathy

TNYA Ratings Summary

TNYA Quant Ranking